ZURA – zura bio limited - class a ordinary shares (US:NASDAQ)
Stock Stats
News
Zura Bio Limited (NASDAQ: ZURA) had its price target raised by analysts at Oppenheimer Holdings Inc. from $16.00 to $21.00. They now have an "outperform" rating on the stock.
Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
Zura Bio Limited (NASDAQ: ZURA) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $26.00 price target on the stock.
Zura Bio Announces Oversubscribed $112.5 Million Private Placement
Zura Bio Announces Robert Lisicki as CEO and Director
Form 10-Q/A Zura Bio Ltd For: Mar 31
Form 8-K Zura Bio Ltd For: May 09
Form 10-Q Zura Bio Ltd For: Mar 31
Form D Zura Bio Ltd
Form SC 13G Zura Bio Ltd Filed by: RA CAPITAL MANAGEMENT, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.